It was demonstrated that cordycepin inhibited the proliferation of B16-BL6 mouse melanoma cells by stimulating adenosine A3 receptors followed by glycogen synthase kinase (GSK)-3β activation and cyclin D1 inhibition [30]. Here, GSK3B is linked to melanoma.